Cargando…
Epigenetically regulated miR-1247 functions as a novel tumour suppressor via MYCBP2 in methylator colon cancers
BACKGROUND: Colorectal cancer (CRC) is a heterogeneous disease with distinct clinical subsets based on underlying genetic and epigenetic changes. DNA hypermethylation yields a unique CRC subset with a distinct phenotype and clinical behaviour, but this oncogenic pathway is not fully characterised. T...
Autores principales: | Liang, Jennifer, Zhou, Wenchao, Sakre, Nneha, DeVecchio, Jennifer, Ferrandon, Sylvain, Ting, Angela H., Bao, Shideng, Bissett, Ian, Church, James, Kalady, Matthew F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251029/ https://www.ncbi.nlm.nih.gov/pubmed/30318507 http://dx.doi.org/10.1038/s41416-018-0249-9 |
Ejemplares similares
-
Epigenetically altered miR-1247 functions as a tumor suppressor in pancreatic cancer
por: Yi, Joo Mi, et al.
Publicado: (2017) -
RBP4-STRA6 Pathway Drives Cancer Stem Cell Maintenance and Mediates High-Fat Diet-Induced Colon Carcinogenesis
por: Karunanithi, Sheelarani, et al.
Publicado: (2017) -
Identifying new targets for rectal cancer treatment
por: Ferrandon, Sylvain, et al.
Publicado: (2020) -
1247. Going Viral with Antimicrobial Stewardship
por: Jenkins, Abi, et al.
Publicado: (2023) -
The GLI genes as the molecular switch in disrupting Hedgehog signaling in colon cancer
por: Mazumdar, Tapati, et al.
Publicado: (2011)